Onset of Vitiligo Within Patients Receiving Immune Checkpoint Inhibitors: An Evidence-Based Review

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY(2024)

引用 0|浏览0
暂无评分
关键词
adverse events,CTLA-4,cutaneous,immune checkpoint inhibitors,melanoma,PD-1,PD-L1,vitiligo
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要